Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07425080 · ClinicalTrials.gov registry record · NA
HELIOS Advanced: Human Oocyte Illumination to Enhance Development
A NA study, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
NCT07425080 is a NA study that is actively recruiting participants, run by Columbia University. The registered enrollment target is 270 participants.
The verdict
NCT07425080, a NA study, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
Study Summary
Oocytes need a lot of energy to complete meiosis and fertilize successfully. As women get older, the "power plants" of the cells (called mitochondria) don't work as well. This makes it harder for eggs and embryos to develop normally. One possible way to help is with a gentle light treatment called photobiomodulation (PBM). This uses a special type of red light that boosts energy production in cells and helps them stay healthy. This study will test whether adding this light treatment during in vitro fertilization (IVF) can improve embryo growth and pregnancy outcomes.
Interventions
- OTHER Photobiomodulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2026-03-24 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07425080
The ClinicalTrials.gov registry entry for NCT07425080 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Photobiomodulation is the first listed.
NCT07425080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07425080 about?
NCT07425080 is a clinical study titled "HELIOS Advanced: Human Oocyte Illumination to Enhance Development". Oocytes need a lot of energy to complete meiosis and fertilize successfully. As women get older, the "power plants" of the cells (called mitochondria) don't work as well. This makes it harder for eggs and embryos to develop normally. One possible way to help is with a gentle light treatment called p...
What is the current status of trial NCT07425080?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2026-03-24. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT07425080?
The interventions under investigation include: Photobiomodulation (OTHER).
Who is sponsoring clinical trial NCT07425080?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.